Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Abbott LaboratoriesXSWX:ABT +0.55%80 Days Sales Outstanding is 60.45 as of Jun. 2026, which is 3% above its 10-year median of 58.52. GuruFocus rates XSWX:ABT with a GF Score™ of 80/100 and a GF Value™ of CHF106.72. The stock has 2 warning signs investors should review. Among 810 Medical Devices & Instruments companies, Abbott Laboratories ranks better than 51.98% on this metric.
The historical rank and industry rank for Abbott Laboratories's Days Sales Outstanding or its related term are showing as below:
XSWX:ABT'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 53.12 Med: 58.52 Max: 64.01
Current: 64.01
During the past 13 years, Abbott Laboratories's highest Days Sales Outstanding was 64.01. The lowest was 53.12. And the median was 58.52.
XSWX:ABT's Days Sales Outstanding is ranked better than 51.98% of 810
companies
in the Medical Devices & Instruments industry
Industry Median: 65.28
vs XSWX:ABT: 64.01
Abbott Laboratories's Days Sales Outstanding
declined
from Jun. 2025 (65.24) to Jun. 2026 (60.45).
Abbott Laboratories (XSWX:ABT) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Abbott Laboratories Days Sales Outstanding Related Terms
Abbott Laboratories Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Abbott Laboratories's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:ABT vs SYK, MDT, BSX: Days Sales Outstanding Comparison
For the Medical Devices subindustry, Abbott Laboratories's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Abbott Laboratories Days Sales Outstanding vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Abbott Laboratories's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Abbott Laboratories's Days Sales Outstanding falls into.
Abbott Laboratories Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Abbott Laboratories (XSWX:ABT) has a Days Sales Outstanding of 60.45 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Abbott Laboratories and its competitors. This is near median its historical median of 58.52. Over the past decade, Abbott Laboratories' Days Sales Outstanding has ranged from 53.12 to 64.01. According to the industry distribution chart, Abbott Laboratories ranks #389 out of 810 companies in the Medical Devices & Instruments industry, placing it in the top 48%.
Is Abbott Laboratories' Days Sales Outstanding too high?
Abbott Laboratories' current Days Sales Outstanding of 60.45 is near median its 10-year median of 58.52. Over the past 10 years, this metric has ranged from a low of 53.12 to a high of 64.01. The Medical Devices & Instruments industry median Days Sales Outstanding is 65.28. Abbott Laboratories' value of 60.45 is 7.4% below this industry median. Based on the distribution chart, Abbott Laboratories ranks #389 out of 810 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Abbott Laboratories has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Abbott Laboratories' Days Sales Outstanding compare to SYK and MDT?
According to the Medical Devices & Instruments industry distribution chart, Abbott Laboratories ranks #389 out of 810 companies for Days Sales Outstanding. This puts Abbott Laboratories in the upper half of its industry. The industry median Days Sales Outstanding is 65.28. Abbott Laboratories' value of 60.45 is 7.4% below this benchmark. Historically, Abbott Laboratories' own Days Sales Outstanding has ranged from 53.12 to 64.01 over the past decade. While the company's 10-year median is 58.52 vs. the industry median of 65.28, Abbott Laboratories has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Medical Devices & Instruments company?
The median Days Sales Outstanding among Medical Devices & Instruments companies is 65.28, based on 810 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Abbott Laboratories's current Days Sales Outstanding of 60.45 is 7.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Abbott Laboratories and its competitors. For the Medical Devices & Instruments industry, the median Days Sales Outstanding is 65.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Abbott Laboratories's current Days Sales Outstanding is 60.45, which is near median its own 10-year median of 58.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abbott Laboratories stock overvalued right now?
Abbott Laboratories (XSWX:ABT) has a current Days Sales Outstanding of 60.45. The stock's GF Value™ is CHF106.72, compared to a current price of CHF91.50 — trading 14.3% below its estimated fair value. The current Days Sales Outstanding is 60.45, which is near median its 10-year median of 58.52 and 7.4% below the Medical Devices & Instruments industry median of 65.28. Abbott Laboratories' overall GF Score™ is 80/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Abbott Laboratories (XSWX:ABT), the current Days Sales Outstanding is 60.45 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Abbott Laboratories (XSWX:ABT) Overvalued in 2026?
Based on GuruFocus' analysis, Abbott Laboratories stock appears to be undervalued.
The current stock price of CHF91.50 is trading 14.3% below its estimated GF Value™ of CHF106.72.
Key valuation signals for XSWX:ABT:
Days Sales Outstanding: 60.45 (near median its 10-year median of 58.52)
GF Value™: CHF106.72 vs. price of CHF91.50 (14.3% below fair value)
Industry Position: 7.4% below the Medical Devices & Instruments median (#389 of 810)
No single metric tells the full story. See the XSWX:ABT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
80GF Score
Get the complete analysis for XSWX:ABT
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:ABT has been successfully added to your 
